A randomised, factorial phase II study to determine the optimal dosing regimen for 68Ga-satoreotide trizoxetan as an imaging agent in patients with gastroenteropancreatic neuroendocrine tumours
2021 ◽
pp. jnumed.121.261936
Irene Virgolini
◽
Shadfar Bahri
◽
Andreas Kjaer
◽
Henning Gronbaek
◽
Peter Iversen
◽
...
2013 ◽
Vol 109
(6)
◽
pp. 1414-1419
◽
H K Ahn
◽
J Y Choi
◽
K-M Kim
◽
H Kim
◽
S-H Choi
◽
...
2016 ◽
Vol 27
◽
pp. vi145
J. Capdevila
◽
A. Teulé
◽
J. Barriuso
◽
D. Castellano
◽
C. Lopez
◽
...
2019 ◽
Vol 123
◽
pp. 92-100
Thomas Walter
◽
Come Lepage
◽
Romain Coriat
◽
Emilie Barbier
◽
Guillaume Cadiot
◽
...
2010 ◽
Vol 38
(2)
◽
pp. 302-311
◽
Phillip G. Claringbold
◽
Paul A. Brayshaw
◽
Richard A. Price
◽
J. Harvey Turner
2005 ◽
Vol 3
(2)
◽
pp. 204
◽
2014 ◽
Vol 25
(4)
◽
pp. 852-858
◽
R.T. Morris
◽
R.N. Joyrich
◽
R.W. Naumann
◽
N.P. Shah
◽
A.H. Maurer
◽
...
Marta Martín-Richard
◽
Bartomeu Massutí
◽
Eva Pineda
◽
Vicente Alonso
◽
Maribel Marmol
◽
...
2015 ◽
Vol 51
◽
pp. S422-S423
R.P. Baum
◽
A.K. Kluge
◽
H.R. Kulkarni
◽
M. Sayeg
◽
U. Schorr-Neufing
◽
...
A J A T Braat
◽
R. van Rooij
◽
R.C.G. Bruijnen
◽
M N G J A Braat
◽
F. Wessels
◽
...
Close
Export Citation Format
Close
Share Document
Close